Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R2-CHOP2 in Follicular Lymphoma
NCT01393756Phase 2Completed
- Sponsor
- LYSARC
- Start
- Dec 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in follicular lymphoma (FL), sponsored by LYSARC. Started Dec 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01393756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393756.